Financialized corporations in a national innovation system : the US pharmaceutical industry
Year of publication: |
2018
|
---|---|
Authors: | Tulum, Öner ; Lazonick, William |
Published in: |
International journal of political economy : a journal of translations. - Philadelphia, Pa. : Routledge, Taylor & Francis Group, ISSN 0891-1916, ZDB-ID 1004721-9. - Vol. 47.2018, 3/4, p. 281-316
|
Subject: | financialization | European pharmaceutical industry | predatory value extraction | productivity of pharma drug innovation | stock buybacks | stock-based pay | the US pharmaceutical industry | USA | United States | Pharmaindustrie | Pharmaceutical industry | Innovation | Arzneimittel | Pharmaceuticals | Industrieforschung | Industrial research | Arzneimittelmarkt | Pharmaceutical market |
-
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona, (2017)
-
Hemphill, Thomas A., (2013)
-
Evaluating Pharmaceutical Policy Options
Ho, Katherine, (2024)
- More ...
-
US Biopharmaceutical Finance and the Sustainability of the Biotech Boom
Lazonick, William, (2010)
-
US biopharmaceutical finance and the sustainability of the biotech business model
Lazonick, William, (2011)
-
Apple's changing business model : what should the world's richest company do with all those profits?
Lazonick, William, (2013)
- More ...